What precaution should be taken when prescribing anthelmintics to pregnant clients?

When prescribing anthelmintics to pregnant clients, it is crucial to recognize that some of these medications may pose significant risks to fetal development. Certain anthelmintic agents can cross the placental barrier and potentially affect the growing fetus, leading to adverse outcomes such as teratogenic effects or developmental abnormalities. Therefore, the potential risks associated with specific medications need careful consideration, and healthcare providers should weigh these risks against the benefits of treating the parasitic infection.

While some anthelmintics may be deemed safe, the general guideline is to approach their use during pregnancy with caution due to the variability in safety profiles among different drugs. Understanding which medications are contraindicated or considered risky is essential for safeguarding both maternal and fetal health.